Study Start Up Associate - (Global ICF)

Study Start Up Associate (Informed Consent)

At ICON, it's our people that set us apart.

As a global provider of drug development solutions, our work is serious business. But that doesn't mean you can't have fun while you do it. With our vision to be the partner of choice in drug development, we hire only the best and brightest in the industry. Are you one of them?

We are looking for someone with Informed Consent Form review experience (ICF Reviewer) to join our Study Start Up group. Our Study Start Up associates are integral in ensuring that physicians at research sites are prepared to start the trial of investigational, new pharmaceutical and biological products for clinical trials at their local practices.

The role

• Your main role is to review Informed Consent Forms and negotiate language as needed
• You will review and negotiate these changes and potentially liaise with other stakeholders like the sponsor, legal, or the clinical team to ensure that changes to the ICF are acceptable.
• You will assist in the drafting of ICF country templates for the United States and Canada, which are then distributed to study sites to make edits depending on their local IRB requirements and SOPs

What you need

• Associates who have a background in clinical research at a CRO, Pharmaceutical company, study site, or who have worked at an IRB
• Performing ICF review as an essential function of the job
• Bachelor's degree in the life sciences is preferred

Why join us?

Ongoing development is vital to us, and as a Study Start Up Associate you will have the opportunity to progress your career, with the potential to move into other related areas to enhance your skill set. Our benefits package is competitive, our scope is international and we genuinely care about our people and their success.

ICON is an equal opportunity employer and committed to providing a workplace free of any discrimination or harassment.

EOE race/color/religion/sex/sexual orientation/gender identity/disability/vet/national origin

#LI-SB1